Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SERPLULIMAB vs SEVELAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SERPLULIMAB vs SEVELAMER: Safety Overview

Metric SERPLULIMAB SEVELAMER
Total FAERS Reports 137 5,712
Deaths Reported 36 284
Death Rate 26.3% 5.0%
Hospitalizations 81 816
Average Patient Age 63.0 yrs 57.9 yrs
% Female Patients 11.1% 46.3%
FDA Approval Date N/A Apr 19, 2023
Manufacturer N/A NorthStar RxLLC
Route N/A ORAL
Marketing Status N/A Discontinued